Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Jul 26;14:1243304. doi: 10.3389/fphar.2023.1243304

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

Yingying Liu 1, Yingying Tan 1, Jiaqi Huang 1, Chao Wu 1, Xiaotian Fan 1, Antony Stalin 2, Shan Lu 1, Haojia Wang 1, Jingyuan Zhang 1, Fanqin Zhang 1, Zhishan Wu 1, Bing Li 3, Zhihong Huang 1, Meilin Chen 1, Guoliang Cheng 3,*, Yanfang Mou 3,*, Jiarui Wu 1,*
PMCID: PMC10411345  PMID: 37564177

Graphical Abstract

graphic file with name FPHAR_fphar-2023-1243304_wc_abs.jpg

Keywords: nonalcoholic simple fatty liver, high-fat diet, intestinal flora disorder, 16S sequencing, network pharmacology


In the published article, there was an error in the Graphical Abstract as published. The number of weeks in the picture are incorrect. The Graphical Abstract has been corrected.

Additionally, a correction has been made to the section Abstract, subsection Methods, 2nd sentence. This sentence previously stated:

“In this study, C57BL/6J mice were fed a high-fat diet for 8 weeks, and the high-fat diet plus HRG or polyene phosphatidylcholine capsules were each administered by gavage for 4 weeks.”

The corrected sentence appears below:

“In this study, C57BL/6J mice were fed a high-fat diet for 10 weeks, and the high-fat diet plus HRG or polyene phosphatidylcholine capsules were each administered by gavage for 5 weeks.”

Lastly, a correction has been made to section Materials and Methods, subsection Animal Grouping and Model Establishment, 2nd and 3rd sentences. These sentences previously stated:

“After 12 consecutive weeks, relevant indicators were evaluated. Mice that passed the evaluation could be considered successful modeling, gavage at week 13, and sampled at week 17.”

The corrected sentences appear below:

“After 10 consecutive weeks, relevant indicators were evaluated. Mice that passed the evaluation could be considered successful modeling, gavage at week 12, and sampled at week 17.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES